Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy
Theranostics · 2025
DOI: 10.7150/thno.108931 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2025. Verfasst von Wenhu Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Adenosine, Nanostructures. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, P. R. China.
Zitieren
APA
Zhu, W., Wu, F., Qiao, Z., Zhao, M., & Hu, H. (2025). Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy. Theranostics. https://doi.org/10.7150/thno.108931
Vancouver
Zhu W, Wu F, Qiao Z, Zhao M, Hu H. Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy. Theranostics. 2025. doi:10.7150/thno.108931
BibTeX
@article{Zhu2025,
author = {Zhu, Wenhu and Wu, Fei and Qiao, Zhanhong and Zhao, Ming and Hu, Haiyang},
title = {Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.108931}
}
EUVIMED